RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RNXT RenovoRx Inc

盘后交易 03-31 17:46:39 EDT

1.01

-0.06

-5.61%

盘后1.05

+0.04+3.96%

17:40 EDT

最高1.10	最低0.9945	成交量67.07万
今开1.09	昨收1.07	日振幅9.86%
总市值4,550万	流通市值4,356万	总股本4,505万
成交额70.33万	换手率1.56%	流通股本4,313万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RNXT","market":"US","secType":"STK","nameCN":"RenovoRx Inc","latestPrice":1.01,"timestamp":1774987200000,"preClose":1.07,"halted":0,"volume":670736,"hourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.01,"latestTime":"17:40 EDT","volume":3137,"amount":3270.4677430999996,"timestamp":1774993245953,"change":0.04,"changeRate":0.039604,"amplitude":0.039604},"delay":0,"changeRate":-0.056074766355140235,"floatShares":43131400,"shares":45052700,"eps":-0.3554,"marketStatus":"盘后交易","change":-0.06,"latestTime":"03-31 17:46:39 EDT","open":1.09,"high":1.1,"low":0.9945,"amount":703291.8485999999,"amplitude":0.098598,"askPrice":1.05,"askSize":421,"bidPrice":1.03,"bidSize":4994,"shortable":0,"etf":0,"ttmEps":-0.3554,"tradingStatus":3,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1775001600000},"marketStatusCode":4,"adr":0,"listingDate":1629950400000,"exchange":"NASDAQ","adjPreClose":1.07,"preHourTrading":{"tag":"盘前","latestPrice":1.0695,"preClose":1.07,"latestTime":"08:48 EDT","volume":2537,"amount":2638.3749682000002,"timestamp":1774961331240,"change":-0.0005,"changeRate":-0.000467,"amplitude":0.046262},"postHourTrading":{"tag":"盘后","latestPrice":1.05,"preClose":1.01,"latestTime":"17:40 EDT","volume":3137,"amount":3270.4677430999996,"timestamp":1774993245953,"change":0.04,"changeRate":0.039604,"amplitude":0.039604},"volumeRatio":0.995845},"requestUrl":"/m/hq/s/RNXT/wiki","defaultTab":"wiki","newsList":[{"id":"1122325500","title":"RenovoRx成立Renovocath医学顾问委员会，助力临床与战略计划","url":"https://stock-news.laohu8.com/highlight/detail?id=1122325500","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1122325500?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:35","pubTimestamp":1770730514,"startTime":"0","endTime":"0","summary":"RenovoRx Inc宣布正式组建Renovocath医学顾问委员会。该委员会的成立旨在为公司当前的临床项目及未来战略发展提供专业指导与支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132291252","title":"RenovoRx公布支持Tamp™治疗平台的临床数据将亮相Sio 2026年度科学大会","url":"https://stock-news.laohu8.com/highlight/detail?id=1132291252","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132291252?lang=zh_cn&edition=full","pubTime":"2026-02-04 21:34","pubTimestamp":1770212075,"startTime":"0","endTime":"0","summary":"RenovoRx公司宣布，其支持Tamp™治疗平台的临床数据将在2026年Sio年度科学会议上进行展示。这一重要研究成果的发布，标志着该公司在创新疗法领域取得了新的突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584030961","title":"Renovorx, Inc.盘中异动 早盘快速上涨7.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2584030961","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584030961?lang=zh_cn&edition=full","pubTime":"2025-11-18 22:31","pubTimestamp":1763476315,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日22时31分，Renovorx, Inc.股票出现波动，股价大幅拉升7.57%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.43%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223155a702242e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118223155a702242e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581140480","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581140480","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581140480?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:14","pubTimestamp":1762445645,"startTime":"0","endTime":"0","summary":"北京时间2025年11月07日00时14分，Renovorx, Inc.股票出现异动，股价快速跳水5.34%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.96%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107001405a6e66184&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107001405a6e66184&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148550558","title":"RenovoRx加强科学顾问委员会，迎来胰腺癌专家Timothy Donahue博士","url":"https://stock-news.laohu8.com/highlight/detail?id=1148550558","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148550558?lang=zh_cn&edition=full","pubTime":"2025-11-06 21:31","pubTimestamp":1762435870,"startTime":"0","endTime":"0","summary":"RenovoRx加强科学顾问委员会，迎来了胰腺癌专家Timothy Donahue博士。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579562187","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579562187","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579562187?lang=zh_cn&edition=full","pubTime":"2025-10-29 23:23","pubTimestamp":1761751423,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日23时23分，Renovorx, Inc.股票出现异动，股价急速下跌5.30%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.02%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102923234394e3f2e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102923234394e3f2e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2577372218","title":"Renovorx, Inc.盘中异动 股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2577372218","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2577372218?lang=zh_cn&edition=full","pubTime":"2025-10-22 23:15","pubTimestamp":1761146111,"startTime":"0","endTime":"0","summary":"北京时间2025年10月22日23时15分，Renovorx, Inc.股票出现异动，股价急速下挫5.04%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.24%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022231511973cd62b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251022231511973cd62b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1165331295","title":"RenovoRx Inc扩充科学顾问委员会，迎来国际知名介入肿瘤学专家Thierry De Baère医学博士","url":"https://stock-news.laohu8.com/highlight/detail?id=1165331295","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1165331295?lang=zh_cn&edition=full","pubTime":"2025-10-09 20:32","pubTimestamp":1760013132,"startTime":"0","endTime":"0","summary":"RenovoRx Inc扩充科学顾问委员会，迎来国际知名介入肿瘤学专家Thierry De Baère医学博士","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514013871","title":"Renovorx, Inc.盘中异动 快速跳水6.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514013871","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514013871?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:43","pubTimestamp":1740494624,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时43分，Renovorx, Inc.股票出现波动，股价快速下挫6.99%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224345a2538a2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225224345a2538a2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775835","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.07%报0.978美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775835","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775835?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:49","pubTimestamp":1740412145,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时49分，Renovorx, Inc.股票出现异动，股价急速跳水5.07%。截至发稿，该股报0.978美元/股，成交量5.7118万股，换手率0.16%，振幅5.82%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.28%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234905abdb2057&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224234905abdb2057&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512963631","title":"Renovorx, Inc.盘中异动 下午盘快速拉升5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512963631","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512963631?lang=zh_cn&edition=full","pubTime":"2025-02-19 03:02","pubTimestamp":1739905374,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日03时02分，Renovorx, Inc.股票出现波动，股价急速拉升5.77%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190302549627c30f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502190302549627c30f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511690892","title":"Renovorx, Inc.盘中异动 临近午盘急速拉升5.83%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511690892","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511690892?lang=zh_cn&edition=full","pubTime":"2025-02-15 00:32","pubTimestamp":1739550751,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日00时32分，Renovorx, Inc.股票出现波动，股价急速拉升5.83%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.69%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150032329885a625&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502150032329885a625&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511352524","title":"Renovorx, Inc.盘中异动 股价大跌5.17%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511352524","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511352524?lang=zh_cn&edition=full","pubTime":"2025-02-13 23:36","pubTimestamp":1739460977,"startTime":"0","endTime":"0","summary":"北京时间2025年02月13日23时36分，Renovorx, Inc.股票出现异动，股价快速下挫5.17%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.36%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233617a244b97c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213233617a244b97c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510805053","title":"Renovorx, Inc.盘中异动 股价大跌5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510805053","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510805053?lang=zh_cn&edition=full","pubTime":"2025-02-11 22:46","pubTimestamp":1739285204,"startTime":"0","endTime":"0","summary":"北京时间2025年02月11日22时46分，Renovorx, Inc.股票出现异动，股价急速下挫5.22%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为1.60%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224644a241fe53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211224644a241fe53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4139","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2510865313","title":"Renovorx, Inc.盘中异动 早盘股价大跌5.17%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510865313?lang=zh_cn&edition=full","pubTime":"2025-02-10 22:35","pubTimestamp":1739198153,"startTime":"0","endTime":"0","summary":"北京时间2025年02月10日22时35分，Renovorx, Inc.股票出现异动，股价急速下挫5.17%。截至发稿，该股报1.10美元/股，成交量1.4272万股，换手率0.06%，振幅4.25%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223554abc9a68d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250210223554abc9a68d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509744760","title":"Renovorx, Inc.股价重挫12.33% 市值跌378.8万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509744760","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509744760?lang=zh_cn&edition=full","pubTime":"2025-02-07 22:30","pubTimestamp":1738938622,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日22时30分，Renovorx, Inc.股票出现异动，股价急速下跌12.33%。截至发稿，该股报1.28美元/股，成交量9.2024万股，换手率0.38%，振幅0.00%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.00%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223023abc62a58&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207223023abc62a58&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505869596","title":"Renovorx, Inc.盘中异动 大幅上涨7.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505869596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505869596?lang=zh_cn&edition=full","pubTime":"2025-01-24 22:31","pubTimestamp":1737729076,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日22时31分，Renovorx, Inc.股票出现异动，股价快速拉升7.97%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.30%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223116abb74e2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124223116abb74e2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RNXT","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505104664","title":"Renovorx, Inc.盘中异动 临近午盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2505104664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505104664?lang=zh_cn&edition=full","pubTime":"2025-01-24 00:51","pubTimestamp":1737651107,"startTime":"0","endTime":"0","summary":"北京时间2025年01月24日00时51分，Renovorx, Inc.股票出现异动，股价快速下挫5.07%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为0.46%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124005147960e5f7c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250124005147960e5f7c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","RNXT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2505203882","title":"Renovorx, Inc.盘中异动 早盘股价大涨5.33%报1.58美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2505203882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2505203882?lang=zh_cn&edition=full","pubTime":"2025-01-21 23:51","pubTimestamp":1737474693,"startTime":"0","endTime":"0","summary":"北京时间2025年01月21日23时51分，Renovorx, Inc.股票出现波动，股价大幅拉升5.33%。Renovorx, Inc.股票所在的生物技术行业中，整体涨幅为1.73%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121235133a22a690e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250121235133a22a690e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RNXT","BK4539","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2503918313","title":"Renovorx, Inc.盘中异动 股价大涨6.38%报1.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2503918313","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2503918313?lang=zh_cn&edition=full","pubTime":"2025-01-16 22:33","pubTimestamp":1737037985,"startTime":"0","endTime":"0","summary":"北京时间2025年01月16日22时33分，Renovorx, Inc.股票出现异动，股价大幅拉升6.38%。Renovorx, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Renovorx, Inc.公司简介：RenovoRx Inc 是一家临床阶段的生物制药公司，针对高度未满足的医疗需求开发专有的靶向联合疗法，旨在改善正在接受治疗的癌症患者的治疗结果。RenovoRx 的专利经动脉微灌注治疗平台旨在确保精确的治疗递送，直接靶向肿瘤，同时与全身静脉治疗相比，有可能最大限度地降低治疗的毒性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622330598688be3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025011622330598688be3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","RNXT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.renovorx.com","stockEarnings":[{"period":"1week","weight":-0.036},{"period":"1month","weight":0.2118},{"period":"3month","weight":0.2234},{"period":"6month","weight":-0.2015},{"period":"1year","weight":0.07},{"period":"ytd","weight":0.2737}],"compareEarnings":[{"period":"1week","weight":-0.0357},{"period":"1month","weight":-0.0787},{"period":"3month","weight":-0.0801},{"period":"6month","weight":-0.0546},{"period":"1year","weight":0.1373},{"period":"ytd","weight":-0.0732}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"RenovoRx, Inc.于2012年12月17日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司，为高度未满足的医疗需求开发专有的靶向联合疗法，目标是改善接受治疗的癌症患者的治疗结果。该公司专有的经动脉微灌注（TAMPT）治疗平台旨在确保精确的治疗递送，以直接针对肿瘤，同时潜在地最大限度地降低治疗相对于全身（静脉注射（称为“IV”）治疗）的毒性。","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":-0.049533},{"month":2,"riseRate":0.6,"avgChangeRate":0.102207},{"month":3,"riseRate":0.2,"avgChangeRate":-0.079513},{"month":4,"riseRate":0,"avgChangeRate":-0.164804},{"month":5,"riseRate":0.5,"avgChangeRate":0.046228},{"month":6,"riseRate":0.5,"avgChangeRate":0.03467},{"month":7,"riseRate":0.25,"avgChangeRate":-0.034228},{"month":8,"riseRate":0.25,"avgChangeRate":-0.119414},{"month":9,"riseRate":0.4,"avgChangeRate":-0.050074},{"month":10,"riseRate":0,"avgChangeRate":-0.120676},{"month":11,"riseRate":0.6,"avgChangeRate":0.028303},{"month":12,"riseRate":0.6,"avgChangeRate":0.479671}],"exchange":"NASDAQ","name":"RenovoRx Inc","nameEN":"RenovoRx Inc"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"RenovoRx Inc,RNXT,RenovoRx Inc股票,RenovoRx Inc股票老虎,RenovoRx Inc股票老虎国际,RenovoRx Inc行情,RenovoRx Inc股票行情,RenovoRx Inc股价,RenovoRx Inc股市,RenovoRx Inc股票价格,RenovoRx Inc股票交易,RenovoRx Inc股票购买,RenovoRx Inc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"RenovoRx Inc(RNXT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供RenovoRx Inc(RNXT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}